|
MARS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.98649993624167E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.42310007800984E-10 |
| Normal-vs-Stage2 |
1.117200E-03 |
| Normal-vs-Stage3 |
1.58983937126322E-13 |
| Normal-vs-Stage4 |
1.4432899320127E-15 |
| Stage1-vs-Stage2 |
8.457200E-01 |
| Stage1-vs-Stage3 |
2.346400E-02 |
| Stage1-vs-Stage4 |
3.000600E-04 |
| Stage2-vs-Stage3 |
1.478770E-01 |
| Stage2-vs-Stage4 |
1.979770E-02 |
| Stage3-vs-Stage4 |
1.469420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62647673107585E-12 |
| Normal-vs-AfricanAmerican |
1.794390E-02 |
| Normal-vs-Asian |
1.197790E-02 |
| Caucasian-vs-AfricanAmerican |
1.365960E-01 |
| Caucasian-vs-Asian |
6.754600E-01 |
| AfricanAmerican-vs-Asian |
7.653800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.60320000000192E-05 |
| Male-vs-Female |
2.40919999999756E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.14499999481765E-08 |
| Normal-vs-Age(41-60Yrs) |
5.58442181386454E-14 |
| Normal-vs-Age(61-80Yrs) |
1.0489997759322E-10 |
| Normal-vs-Age(81-100Yrs) |
7.800900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.357400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.171650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.111600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.763760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.422400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.191600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.040820E-01 |
| Normal-vs-Grade 2 |
1.83880000115266E-09 |
| Normal-vs-Grade 3 |
1.97541982771554E-12 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
8.992400E-01 |
| Grade 1-vs-Grade 3 |
4.507000E-01 |
| Grade 1-vs-Grade 4 |
1.610840E-01 |
| Grade 2-vs-Grade 3 |
5.918000E-02 |
| Grade 2-vs-Grade 4 |
1.51290999998999E-05 |
| Grade 3-vs-Grade 4 |
8.957300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.95489999965659E-07 |
| Normal-vs-ccB subtype |
1.12465592394528E-13 |
| ccA subtype-vs-ccB subtype |
6.861200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.15447667986746E-12 |
| Normal-vs-N1 |
1.53837999999906E-05 |
| N0-vs-N1 |
5.213000E-01 |
|
|
